Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of the amino acids l-ornithine and l-aspartate. It is primarily used in the management of hyperammonemia associated with liver insufficiency.
## Primary Indications
* Hepatic encephalopathy (HE)
* Hyperammonemia in patients with liver disease
## Adult Dosing
* **Hepatic Encephalopathy/Hyperammonemia:** The typical dose is 20 mL (containing 10 g l-ornithine and 10 g l-aspartate) infused intravenously over 30 minutes, 3 times daily.
* Dosing can be adjusted based on the patient's response and tolerance. Maximum daily dose information is not clearly established and depends on clinical judgment and local protocols.
## Pediatric Dosing
* Pediatric dosing is not well-established. Use in pediatric patients should be guided by specialist advice and careful monitoring.
## Dose Adjustments
* No specific dose adjustments are typically recommended for renal or hepatic impairment, as the drug is intended for patients with liver disease. However, close monitoring is essential.
## Contraindications
* Hypersensitivity to l-ornithine or l-aspartate.
* Severe renal impairment.
## Adverse Effects
* Nausea, vomiting, abdominal discomfort.
* Rarely, allergic reactions.
* Electrolyte disturbances (e.g., hyperkalemia) have been reported, particularly with rapid infusion.
## Key Drug Interactions
* No significant drug interactions are widely reported. However, caution may be warranted with other medications affecting ammonia levels or electrolyte balance.
## Monitoring
* Monitor for signs and symptoms of hepatic encephalopathy.
* Monitor electrolytes, especially potassium and renal function, particularly with rapid infusions or in patients with pre-existing renal issues.
* Assess for gastrointestinal side effects.
## Clinical Pearls
* The mechanism of action involves promoting the detoxification of ammonia in the liver and peripheral tissues.
* Infusion rate should be carefully controlled to minimize side effects.
* Effectiveness may vary depending on the severity and cause of liver disease.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines for the most up-to-date and comprehensive details before making any treatment decisions.*
